Did lxrx receive fda approval on 10/31/2024

Lexicon Pharmaceuticals (LXRX) did not receive FDA approval on October 31, 2024, for its drug ZYNQUISTA (sotagliflozin). The FDA approval status is pending as of the review date October 31, 2024, indicating that the FDA review is still in progress and has not yet resulted in approval.